FDA recall D-067-2013

Boehringer Ingelheim Roxane Inc · Class II · drug

Product

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

Reason for recall

Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2012-11-05
Report date
2012-12-05
Termination date
2013-09-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Columbus, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-067-2013